A Study of LY3127804 in Participants With COVID-19

I7W-MC-UDAA -

This study is a randomized, double-blind, placebo-controlled, clinical trial designed to evaluate LY3127804 in participants who are hospitalized with pneumonia and presumed or confirmed COVID-19.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
What the trial is testing?
Could I receive a Placebo?
Yes
Enrollment Goal
95
Trial Dates
Apr 20, 2020 - Oct 12, 2020
How long will I be in the trial?
The study may last up to 9 weeks and include daily visits up to day 28, and follow-up visits by phone.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.